TVRD- Tvardi Therapeutics, Inc.

Name: Tvardi Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Tvardi Therapeutics, Inc. (TVRD) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TVRD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Alibhai Imran Nizamudin	47.5K	$198.6K	-
Other	Kauh John Saewook M.D.	17.5K	$73.2K	-
CFO	Conn Avi Daniel	17.5K	$73.2K	-
Other	O'Brien Stephen Paul	4.0K	$16.7K	-
10%	Tweardy Samuel David	0	-	-

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Mar 13, 2019	Mohindru Mani	CFO &Chief Strategy Officer	Sale+OE	16,041	$19.12	$306,703.92	-66.7%
Mar 13, 2019	Menzaghi Frederique Ph.d.85	Chief Scientific Off,Svp-r&D	Sell	20,000	$18.65	$373,020.11	-7.1%
Mar 1, 2019	Chalmers Derek T	President &CEO	Sell	9,792	$17.04	$166,855.68	-1.0%
Feb 28, 2019	Menzaghi Frederique Ph.d.85	Sr Vp-research &Development	Sell	1,500	$17.50	$26,250.00	-1.0%
Feb 25, 2019	Menzaghi Frederique Ph.d.85	Sr Vp-research &Development	Sell	2,200	$17.50	$38,500.00	-1.5%
Feb 1, 2019	Chalmers Derek T	President &CEO	Sell	20,000	$14.99	$299,800.00	-2.1%
Jan 4, 2019	Chalmers Derek T	President &CEO	Sell	20,000	$13.61	$272,150.00	-1.0%
Dec 28, 2018	Menzaghi Frederique Ph.d.85	Sr Vp-research &Development	Sell	4,300	$12.53	$53,879.00	-2.9%
Dec 28, 2018	Terrillion Scott90	Sec'y; Chief Compliance &G.c.	Sell	3,100	$12.51	$38,781.00	-32.7%
Dec 28, 2018	Chalmers Derek T	President &CEO	Sell	15,825	$12.53	$198,287.25	-1.6%

← PrevPage 14Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC